<DOC>
	<DOCNO>NCT00000758</DOCNO>
	<brief_summary>To determine efficacy safety intravaginal fluorouracil administer prophylaxis HIV-infected woman receive standard ablative therapy ( surgery ) high-grade cervical dysplasia ( pre-cancer cervix ; cervical intraepithelial neoplasia ) . To correlate time recurrence cervical dysplasia T-cell function . Women HIV infection great risk cervical dysplasia . Because likelihood untreated recurrent cervical dysplasia may progress invasive cancer , urgent need develop appropriate therapy .</brief_summary>
	<brief_title>A Phase III Randomized Trial Topical Vaginal Fluorouracil ( 5-Fluorouracil , 5-FU ) Maintenance Therapy Versus Observation After Standard Treatment High-Grade Cervical Dysplasia HIV-Infected Women</brief_title>
	<detailed_description>Women HIV infection great risk cervical dysplasia . Because likelihood untreated recurrent cervical dysplasia may progress invasive cancer , urgent need develop appropriate therapy . Patients randomize receive either intravaginal fluorouracil treatment ( observation ) . Fluorouracil cream self-administered via applicator biweekly interval 6 month . Patients evaluate recurrent cervical dysplasia cytology colposcopy without biopsy .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Uterine Cervical Dysplasia</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Antiretrovirals ( AZT , ddI , ddC ) immunomodulators ( interferon interleukin ) . Prophylaxis treatment opportunistic infection . Vaginal antifungal agent indicate vaginal medication ( although permit day fluorouracil application ) . Contraceptives . Acyclovir ( prophylaxis treatment ) patient history primary recurrent genital herpes . Patients must : HIV infection . Prior cervical dysplasia ( grade II III cervical intraepithelial neoplasia ) successfully treat ablative procedure within past 12 week . Patients le 18 year age must consent parent guardian . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Untreated persistent vaginal vulvar dysplasia . Colposcopy biopsy inconclusive positive dysplasia . Active genital ulcerative disease syphilitic chancre herpes ulcer . Adenocarcinoma situ . Concurrent Medication : Excluded : Cytotoxic chemotherapy malignancy . Highdose steroid ( &gt; 10 mg/day prednisone steroid equivalent ) . Patients follow prior condition exclude : Malignancy require cytotoxic chemotherapy within 3 month prior study entry . Prior hysterectomy . History allergic reaction severe hypersensitivity fluorouracil . Prior Medication : Excluded : Fluorouracil ( systemic topical ) within 3 month prior study entry .</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Fluorouracil</keyword>
	<keyword>Cervix Dysplasia</keyword>
	<keyword>Cervix Diseases</keyword>
</DOC>